CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 134 enrolled
Drug / intervention
Bard Luminexx Iliac Stent and Delivery Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00561457
NCT00561457N/ACompleted
CompareCT.gov

A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System

C. R. Bard·interventional·Posted Nov 21, 2007·Updated Mar 1, 2017

In Brief

A clinical study evaluating Bard Luminexx Iliac Stent and Delivery System for Iliac Artery Occlusive Disease. Completed, enrolled 134 participants.

Detailed Summary

To determine the safety and effectiveness of the LUMINEXX stent for the proposed indication of treatment of common and/or external iliac artery occlusive disease

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIliac Artery Occlusive Disease
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 21, 2007
Enrollment StartJun 1, 2003
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 18.6 years ago

Interventions

Bard Luminexx Iliac Stent and Delivery Systemdevice

Iliac Stenting